Relive the best moments
Pictures
Welcome
ILCA School Of Liver Cancer
Thanks to the collaborative support of The Chinese University of Hong Kong (CUHK), we are thrilled to announce that Hong Kong was chosen for this edition of the ILCA School of Liver Cancer 2023.
The ILCA School is a unique learning platform for practitioners and investigators to receive education in an intense, interactive, and multidisciplinary format. This one-day ILCA School covers the latest developments in liver cancer research and treatment, including updates on tumour biology, clinical trial advances, and expert insights on management strategies. Additionally, we will help to enhance your research tools, such as oral presentation and statistical interpretation skills. Join us for a productive and engaging meeting!
Date: 17th June 2023: from 8.30 a.m. – 5.00 p.m. (GMT+8)
Location: LT3 (G/F), Esther Lee Building, The Chinese University of Hong Kong (CUHK), Shatin, N.T., HKSAR, China
Mode: ILCA School took place both in person and virtually
This one-day multidisciplinary ILCA School covered:
- Updates of the latest development on tumour biology of liver cancers
- Summary and discussion of latest advances in clinical trials on liver cancers including hepatocellular carcinoma and cholangiocarcinoma
- Experts’ opinion on the management of liver cancer with illustrative examples
- Strengthening your tools of researching including oral presentation and statistical interpretation of papers
Programme
| Time GMT+8 | Topic | Proposed speaker | |
|---|---|---|---|
| Opening | 8:30-8:45am | Welcome remarks | Stephen L. CHAN Department of Clinical Oncology, CUHK |
| Session 1 | Liver cancer: Bench to Bedside | Chairs: Nathalie WONG, Department of Surgery, CUHK Alfred CHENG, School of Biomedical Sciences, CUHK |
|
| 8:50-9:10am | Biomarker for surveillance of HCC: Beyond AFP | Landon CHAN Department of Clinical Oncology, CUHK |
|
| 9:10-9:30am | Strategies to enhance immunotherapy for HCC: Lessons from animal models | Alfred CHENG School of Biomedical Sciences, CUHK |
|
| 9:30-9:50am | Tumour heterogeneity in HCC | Pierce CHOW National Cancer Centre Singapore |
|
| 9:50-10:10am | Circulating nucleic acid on management of liver cancers: Ready for use? | Jacky LAM Department of Chemical Pathology, CUHK |
|
| 10:10-10:30am | Discussion (including Q&A) | ||
| Coffee Break | 10:30-10:40am | ||
| Session 2 | Clinical advances on management of HCC | Chairs: Stephen L. CHAN, Department of Clinical Oncology, CUHK Tan To CHEUNG, Department of Surgery, HKU |
|
| 10:40-11:00am | Conversion therapy for HCC: Development in China | Huichuan SUN, Zhongshan Hospital, Fudan University | |
| 11:00-11:20am | The changing role of TACE in 2023 | Stephen L. CHAN, Department of Clinical Oncology, CUHK | |
| 11:20-11:40am | Drug therapy for HCC: Present and Future | Lorenza RIMASSA, Humanitas University | |
| 11:40-12:00noon | Tumour Board 2 cases | Stephen L. CHAN Tan To CHEUNG Pierce CHOW Chiun HSU Lorenza RIMASSA Huichuan SUN |
|
| 12:00-12:20pm | Discussion (Q & A) | ||
| Lunch | 12:20-2:00pm | ||
| Session 3 | Bile duct cancer: An update | Chairs: Chiun HSU, Graduate Institute of Oncology, National Taiwan University Rashid LUI, Department of Medicine & Therapeutics, CUHK |
|
| 2:00-2:20pm | Is there any role of liver transplantation for Intrahepatic cholangiocarcinoma? | Albert CHAN, Department of Surgery, HKU | |
| 2:20-2:40pm | An update of systemic treatment for Biliary Tract Cancer | Lorenza RIMASSA, Humanitas University | |
| 2:40-3:00pm | Endoscopic management for biliary tract cancers | Anthony TEOH, Department of Surgery, CUHK | |
| 3:00-3:20pm | Discussion (Q & A) | ||
| Coffee Break | 3:20-3:30pm | ||
| Session 4 | The art of research and patients’ management in liver cancer | Chairs: Grace WONG, Department of Medicine & Therapeutics, CUHK Tiffany WONG, Department of Surgery, HKU |
|
| 3:30-3:50pm | The art of oral presentation | Chiun HSU, Graduate Institute of Oncology, National Taiwan University |
|
| 3:50-4:10pm | Management of HBV and HCV in liver cancer | Grace WONG, Department of Medicine and Therapeutics, CUHK | |
| 4:10-4:30pm | How to interpret a paper: from a biostatistician’s angle | Terry CF YIP, Department of Medicine and Therapeutics, CUHK | |
| 4:30-4:50pm | Discussion (Q&A) | ||
| Closing | 4:50-5:00pm | Closing remarks and acknowledgements | Stephen L. CHAN, Department of Clinical Oncology, CUHK |
The venue
Location: LT3 (G/F), Esther Lee Building, The Chinese University of Hong Kong (CUHK), Shatin, N.T., HKSAR, China
Severe Weather Arrangement
• Morning session will be cancelled if “Extreme Situation”, typhoon signal no.8 or above or black rain signal remains hoisted at 7:00am or the HK Observatory announces that “Extreme Situation”, typhoon no. 8 or black rain signal will be hoisted at/after 7:00am.
• Afternoon session will be cancelled if “Extreme Situation”, typhoon signal no.8 or above or black rain signal remains hoisted at 12:00 noon or the HK Observatory announces that “Extreme Situation”, typhoon no. 8 or black rain signal will be hoisted at/after 12:00 noon.
• To see the latest weather reports, please visit the Hong Kong Observatory.
Grant
The ILCA School of Liver Cancer 2023 is supported by an unrestricted educational grant from Bayer
